These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 33585901)

  • 1. Characterizing a two-pronged epidemic in Mexico of non-communicable diseases and SARS-Cov-2: factors associated with increased case-fatality rates.
    Monterrubio-Flores E; Ramírez-Villalobos MD; Espinosa-Montero J; Hernandez B; Barquera S; Villalobos-Daniel VE; Campos-Nonato I
    Int J Epidemiol; 2021 May; 50(2):430-445. PubMed ID: 33585901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study.
    Drozd M; Pujades-Rodriguez M; Lillie PJ; Straw S; Morgan AW; Kearney MT; Witte KK; Cubbon RM
    Lancet Infect Dis; 2021 Aug; 21(8):1184-1191. PubMed ID: 33662324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic non-communicable diseases in the epidemic (COVID-19): Investigation of risk factors, control and care.
    Aleebrahim-Dehkordi E; Deravi N; Reyhanian A; Saberianpour S; Mokhtari M; Hasanpour-Dehkordi A
    Przegl Epidemiol; 2020; 74(3):449-456. PubMed ID: 33570342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case-fatality rate of SARS-CoV-2 infection during the third and fifth epidemic waves in Spain: Impact of vaccination.
    Martín-Sánchez V; Ruiz-Garcia A; Vitelli-Storelli F; Serrano-Cumplido A; Barquilla-Garcia A; Micó-Pérez RM; Olmo-Quintana V; Calderón-Montero A; Segura-Fragoso A
    Semergen; 2023 Oct; 49(7):102026. PubMed ID: 37356278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico.
    Hernández-Galdamez DR; González-Block MÁ; Romo-Dueñas DK; Lima-Morales R; Hernández-Vicente IA; Lumbreras-Guzmán M; Méndez-Hernández P
    Arch Med Res; 2020 Oct; 51(7):683-689. PubMed ID: 32747155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico.
    Torres-Ibarra L; Basto-Abreu A; Carnalla M; Torres-Alvarez R; Reyes-Sanchez F; Hernández-Ávila JE; Palacio-Mejia LS; Alpuche-Aranda C; Shamah-Levy T; Rivera JA; Barrientos-Gutierrez T
    Int J Epidemiol; 2022 May; 51(2):429-439. PubMed ID: 35157072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demystifying the varying case fatality rates (CFR) of COVID-19 in India: Lessons learned and future directions.
    Asirvatham ES; Lakshmanan J; Sarman CJ; Joy M
    J Infect Dev Ctries; 2020 Oct; 14(10):1128-1135. PubMed ID: 33175707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico.
    Woolcott OO; Castilla-Bancayán JP
    Sci Rep; 2021 Apr; 11(1):8386. PubMed ID: 33863997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interface between SARS-CoV-2 and non-communicable diseases (NCDs) in a high HIV/TB burden district level hospital setting, Cape Town, South Africa.
    Mnguni AT; Schietekat D; Ebrahim N; Sonday N; Boliter N; Schrueder N; Gabriels S; Cois A; Tamuzi JL; Tembo Y; Davies MA; English R; Nyasulu PS
    PLoS One; 2023; 18(10):e0277995. PubMed ID: 37796879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delay-Adjusted Age-Specific COVID-19 Case Fatality Rates in a High Testing Setting: South Korea, February 2020 to February 2021.
    Shim E
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34064703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
    Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
    Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: Evolution in the estimated risk of mortality throughout the epidemic.
    Newall AT; Leong RNF; Nazareno A; Muscatello DJ; Wood JG; Kim WJ
    Int J Infect Dis; 2020 Dec; 101():306-311. PubMed ID: 33011281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
    Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the epidemiological profile of SARS-CoV-2-positive individuals in Mexico across pandemic waves as an explanation of fatality reduction: a retrospective observational study.
    Gutierrez JP; López D; Ascencio I; Juárez A; Olaiz G; Bertozzi SM
    BMJ Open; 2023 May; 13(5):e063211. PubMed ID: 37221025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncommunicable diseases and changes in lifestyles during the COVID-19 pandemic in Brazil.
    Malta DC; Gomes CS; Barros MBA; Lima MG; Almeida WDS; Sá ACMGN; Prates EJS; Machado ÍE; Silva DRPD; Werneck AO; Damacena GN; Souza Júnior PRB; Azevedo LO; Montilla DER; Szwarcwald CL
    Rev Bras Epidemiol; 2021; 24():e210009. PubMed ID: 33950138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIDO COVID: A digital public health strategy designed to tackle chronic disease and the COVID-19 pandemic in Mexico.
    Gallardo-Rincón H; Gascon JL; Martínez-Juárez LA; Montoya A; Saucedo-Martínez R; Rosales RM; Tapia-Conyer R
    PLoS One; 2022; 17(11):e0277014. PubMed ID: 36395257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality comparisons of COVID-19 with all-cause and non-communicable diseases in Cyprus, Iceland and Malta: lessons learned and forward planning.
    Cuschieri S; Pallari E; Hatziyianni A; Sigurvinsdottir R; Sigfusdottir ID; Sigurðardóttir ÁK
    Public Health; 2022 Jan; 202():52-57. PubMed ID: 34891099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in the case-fatality rates for COVID-19-A comparison of the age-related differences and consistency over seven countries.
    Green MS; Nitzan D; Schwartz N; Niv Y; Peer V
    PLoS One; 2021; 16(4):e0250523. PubMed ID: 33914806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.
    Palmer K; Monaco A; Kivipelto M; Onder G; Maggi S; Michel JP; Prieto R; Sykara G; Donde S
    Aging Clin Exp Res; 2020 Jul; 32(7):1189-1194. PubMed ID: 32458356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.